Johannes De Haard

Title: Innovations and Contributions of Johannes De Haard

Introduction

Johannes De Haard is a notable inventor based in Oudelande, Belgium. He has made significant contributions to the field of biotechnology, particularly in the development of binding molecules and engineered antibodies. With a total of 11 patents to his name, De Haard's work has the potential to impact various therapeutic applications.

Latest Patents

Among his latest patents is the development of FcRn/HSA binding molecules and methods of use. This patent provides binding molecules that comprise a human neonatal Fc receptor (FcRn) binding molecule and at least one antigen-binding domain linked to the FcRn binding molecule. Additionally, it includes polynucleotides, vectors, host cells, and methods of production. Another significant patent focuses on methods of preparing pH-dependent antibodies. This innovation discloses methods for creating engineered antibodies that exhibit improved pH-dependent antigen binding by introducing histidine residues at specific amino acid positions within the antibody CDRs. These methods offer a simpler and more efficient approach to identifying pH-dependent antibody variants.

Career Highlights

Throughout his career, Johannes De Haard has worked with prominent companies in the biotechnology sector, including Argenx N.V. and Argenx B.V. His expertise in antibody engineering and therapeutic development has positioned him as a key figure in his field.

Collaborations

De Haard has collaborated with several professionals, including Natalie De Jonge and Anna Hultberg. These collaborations have likely contributed to the advancement of his research and innovations.

Conclusion

Johannes De Haard's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic applications.